Average Insider

Where insiders trade, we follow

Sullivan Christopher Ryan

Chief Financial Officer
CIK: 1810417

All Transactions

DateCompanyTypeSharesPriceValueActions
Sep 16, 2026Avalo Therapeutics, Inc. (AVTX)M12,394$0.00$0.00View Details Filing
Sep 16, 2026Avalo Therapeutics, Inc. (AVTX)M12,394$9.88$122,452.72View Details Filing
Sep 16, 2026Avalo Therapeutics, Inc. (AVTX)S12,394$16.33$202,437.40View Details Filing
Sep 10, 2026Avalo Therapeutics, Inc. (AVTX)S10,185$17.62$179,456.64View Details Filing
Sep 10, 2026Avalo Therapeutics, Inc. (AVTX)M10,185$8.04$81,887.40View Details Filing
Sep 10, 2026Avalo Therapeutics, Inc. (AVTX)M10,185$0.00$0.00View Details Filing
Aug 18, 2026Avalo Therapeutics, Inc. (AVTX)M31,031$9.88$306,586.28View Details Filing
Aug 18, 2026Avalo Therapeutics, Inc. (AVTX)M31,031$0.00$0.00View Details Filing
Aug 18, 2026Avalo Therapeutics, Inc. (AVTX)S31,031$20.05$622,323.60View Details Filing
29 more transactions available โ€” create a free account to see 12 months of history
Version: v26.11.1